Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant MITF anticorps

Cet anticorps Lapin Monoclonal détecte spécifiquement MITF dans IF, FACS et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN6937844

Aperçu rapide pour Recombinant MITF anticorps (ABIN6937844)

Antigène

Voir toutes MITF Anticorps
MITF (Microphthalmia-Associated Transcription Factor (MITF))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 113
  • 48
  • 27
  • 25
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 87
  • 43
  • 1
Lapin

Clonalité

  • 68
  • 63
Monoclonal

Conjugué

  • 67
  • 8
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MITF est non-conjugé

Application

  • 73
  • 51
  • 47
  • 41
  • 34
  • 13
  • 13
  • 12
  • 11
  • 10
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

MITF-2987R
  • Specificité

    MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This MAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi.

    Aucune reactivité croisée

    Souris, Rat (Rattus)

    Réactivité croisée (Details)

    Human. Dog. Does not react with Mouse or Rat.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant full-length human MiTF protein

    Isotype

    IgG
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat, A-431, HeLa or 501 Mel human melanoma cells. Melanoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    MITF (Microphthalmia-Associated Transcription Factor (MITF))

    Autre désignation

    MITF

    Sujet

    BHLHE32, Class E basic helix-loop-helix protein 32 (bHLHe32), CMM8, Mi, Microphthalmia-associated transcription factor, MITF, WS2, WS2A,Microphthalmia Transcription Factor (MITF)
    Cellular localisation: Nuclear

    Poids moléculaire

    52-56kDa (doublet)

    ID gène

    4286, 166017, 618266

    UniProt

    O75030

    Pathways

    Chromatin Binding
Vous êtes ici:
Chat with us!